21-hydroxylase deficiency natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
Line 16: | Line 16: | ||
==Prognosis== | ==Prognosis== | ||
*The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment. | *The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment. | ||
* A small percentage of children and adults with infancy or childhood onset congenital adrenal hyperplasia die of adrenal crisis, even after diagnosis and initiation of treatment. | * A small percentage of children and adults with infancy or childhood onset congenital adrenal hyperplasia die of adrenal crisis, even after diagnosis and initiation of treatment. | ||
* When a person is well, missing a dose or even several doses, may not worsen the immediate symptoms. However, [[glucocorticoid]] needs are increased during illness and stress. | * When a person is well, missing a dose or even several doses, may not worsen the immediate symptoms. However, [[glucocorticoid]] needs are increased during illness and stress. | ||
* Missed doses during time of illness can lead (within hours) to [[hypotension]], [[Shock (medical)|shock]], and death. | * Missed doses during time of illness can lead (within hours) to [[hypotension]], [[Shock (medical)|shock]], and death.<ref name="pmid20823466">{{cite journal |vauthors=Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC |title=Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4133–60 |year=2010 |pmid=20823466 |pmc=2936060 |doi=10.1210/jc.2009-2631 |url=}}</ref><ref name="pmid15554889">{{cite journal |vauthors=van der Kamp HJ, Wit JM |title=Neonatal screening for congenital adrenal hyperplasia |journal=Eur. J. Endocrinol. |volume=151 Suppl 3 |issue= |pages=U71–5 |year=2004 |pmid=15554889 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 14:00, 18 July 2017
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency natural history, complications and prognosis |
FDA on 21-hydroxylase deficiency natural history, complications and prognosis |
CDC on 21-hydroxylase deficiency natural history, complications and prognosis |
21-hydroxylase deficiency natural history, complications and prognosis in the news |
Blogs on 21-hydroxylase deficiency natural history, complications and prognosis |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Mehrian Jafarizade, M.D [2]
Overview
Common complications of 21-hydroxylase deficient congenital adrenal hyperplasia include short stature, adrenal crisis, infertility, and precocious puberty. The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment.
Complications
Common complications associated with 21-hydroxylase deficient congenital adrenal hyperplasia include:[1][2]
Prognosis
- The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment.
- A small percentage of children and adults with infancy or childhood onset congenital adrenal hyperplasia die of adrenal crisis, even after diagnosis and initiation of treatment.
- When a person is well, missing a dose or even several doses, may not worsen the immediate symptoms. However, glucocorticoid needs are increased during illness and stress.
- Missed doses during time of illness can lead (within hours) to hypotension, shock, and death.[1][2]
References
- ↑ 1.0 1.1 Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC (2010). "Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline". J. Clin. Endocrinol. Metab. 95 (9): 4133–60. doi:10.1210/jc.2009-2631. PMC 2936060. PMID 20823466.
- ↑ 2.0 2.1 van der Kamp HJ, Wit JM (2004). "Neonatal screening for congenital adrenal hyperplasia". Eur. J. Endocrinol. 151 Suppl 3: U71–5. PMID 15554889.